Joint Formulary & PAD

Aclidinium bromide (Eklira Genuair) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Aclidinium bromide (Eklira Genuair)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
LAMA
Keywords :
LAMAs, antimuscarinic bronchodilators, respiratory, long-acting muscarinic antagonist
Brand Names Include :
Eklira Genuair
Important Information :

Combination with LABA recommended in COPD.

Prescribe by BRAND

Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
3

Committee Recommendations (1)

The locally preferred LAMA devices are as follows:

  • Spiriva Respimat (tiotropium soft mist inhaler). Re-usable device.
  • Incruse Ellipta (Umeclidinium DPI)
  • Seebri Breezhaler (Glycopyrronium DPI)
  • Eklira Genuair (Aclidinium DPI)

Devices should be prescribed by BRAND

See full COPD guidelines for more information

Other Indications

Below are listed other indications that Aclidinium bromide (Eklira Genuair) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).